This article aims to review the present status of anti-flavivirus subunit vaccines, both those at
the experimental stage and those already available for clinical use. Aspects regarding …

Infection caused by the Zika virus (ZIKV) can lead to serious neurological complications
such as microcephaly in neonates. At present, no approved ZIKV vaccine is available, but …

We report the development of a new nanostructured electrochemical immunosensing
platform for the detection of the Zika virus envelope protein (EP-ZIKV). For this, quantum dots …

Zika virus (ZIKV) is a zoonotic, human pathogenic, and mosquito-borne flavivirus. Its
distribution is rapidly growing worldwide. Several attempts to develop vaccines for ZIKV are …

Introduction In the present study we evaluated the features of different recombinant forms of
Zika virus (ZIKV) proteins produced in either bacterial (Eschericha coli) or insect cells …

Recent outbreaks of Zika virus (ZIKV) infection have highlighted the need for a better
understanding of ZIKV-specific immune responses. The ZIKV envelope glycoprotein (EZIKV) …

Zika virus (ZIKV), which belongs to the Flavivirus family, is mainly transmitted via the bite of
Aedes mosquitoes. In newborns, ZIKV infection can cause severe symptoms such as …

Trueperella pyogenes (T. pyogenes) is a crucial opportunistic pathogen normally causing
mastitis, abscesses and pneumonia in economically important ruminants. Although only one …

Aim: To develop, characterize and evaluate an oil/water nanoemulsion with squalene
(CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials …

In 2015, the world witnessed the resurgence and global spread of Zika virus (ZIKV). This
arbovirus infection is associated with Guillain-Barré syndrome in adults and with devastating …